Our data demonstrated a trend toward an increase in obesity-induced Ccl2 expression, which was prevented by SGK1 genetic inhibition (ANOVA P = 0.05). The gene discussed is CCL2; the disease is obesity due to melanocortin 4 receptor deficiency.